A tumour necrosis factor-alpha (TNF-α) promoter polymorphism is associated with chronic hepatitis B infection

Clinical and Experimental Immunology

Volumn 111, Issue 3, 1998, Pages 579-582

  Hohler T ^a   Kruger, A ^a   Gerken, G ^a   Schneider, P M ^a   Meyer Zum Buschenfelde K H ^a   Rittner, C ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Chronic infection; Hepatitis B virus; MHC; Promoter polymorphism; Tumour necrosis factor alpha

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; HEPATITIS B; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; VIRUS INFECTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HEPATITIS B VIRUS; PROSPECTIVE STUDY;

ALLELES; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031594577     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00534.x     Document Type: Article

References (31)

1. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13:29-60.
2. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4:25-36.
3. Guidotti LG, Borrow P, Hobbs MV, Matzke B, Gresser I, Oldstone MBA, Chisari FV. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc Natl Acad Sci USA 1996; 93:4589-94.
4. Sheron N, Lau L, Daniels H, Goka J, Eddleston A, Alexander GJ, Williams R. Increased production of tumor necrosis factor alpha in chronic hepatitis B virus infection. J Hepatol 1991; 12:241-5.
5. Marinos G, Naoumov NV, Rossol S, Torre F, Wong PYN, Gallati H, Portmann B, Williams R. Tumor necrosis factor receptors in patients with chronic hepatitis B infection. Gastroenterol 1995; 108:1453-63.
6. Fang JWS, Shen WW, Meager A, Lau JYN. Activation of the tumor necrosis factor-α system in the liver in chronic hepatitis B virus infection. Am J Gastroenterol 1996; 91:748-53.
7. Wilson AG, De Vries N, Pociot F, Di Giovine FS, Van der Putte LBA, Duff GW. An allelic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177:557-60.
8. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994; 39:150-5.
9. Wilson AG, Symons JA, McDowell TL, Di Giovine FS, Duff GW. Effects of a tumor necrosis factor (TNF-alpha) promoter base transition on transcriptional activity. Br J Rheumatol 1994; 33:89.
10. Pociot F, D'Alfonso S, Compasso S, Scorza R, Richiardi PM. Functional analysis of a new polymorphism in the human TNF α gene promoter. Scand J Immunol 1995; 42:501-4.
11. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwjatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371:508-11.
12. Cabrera M, Shaw MA, Sharples C, Williams H, Castes M, Convit J, Blackwell JM. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995; 182:1259-64.
13. Hill AVS, Ruwende C, Mcguire W et al. Association of the TNF-238 promoter polymorphism with susceptibility to tuberculosis and malaria in Africa. Hum Immunol 1996; 47:118.
14. Höhler T, Gerken G, Notghi N et al. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. J Hepatol 1997; 26:503-7.
15. Dyer P, Warrens A. Design and interpretation of studies of the major histocompatibility complex in disease. In: Lechler R, ed. HLA and disease. London: Academic Press, 1994:93-121.
16. Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992; 48:361-72.
17. Zaykin D, Shivotovsky L, Weir BS. Exact tests for associations between alleles at arbitrary numbers of loci. Genetica 1995; 96:169-78.
18. Thursz MR, Kwiatkowski D, Allsopp CEM, Greenwood BM, Thomas HC, Hill AVS. Association between an MHC class II allele and clearance of the hepatitis B virus in Gambia. N Engl J Med 1995; 332:1065-9.
19. Shakov AN, Collart MA, Vassalli P, Nedospasov SA, Jongeneel CV. κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages. J Exp Med 1990; 171:35-47.
20. Haas JP, Kimura A, Truckenbrodt H, Suschke J, Sasazuki T, Volgger A, Albert ED. Early onset juvenile chronic arthritis is associated with a mutation in the Y-box of the HLA-DQA1 promoter. Tissue Antigens 1995: 45:317-21.
21. Morzycka-Wroblewska E, Munshi A, Ostermayer M, Harwood JI, Kagnoff MF. Differential expression of HLA-DQA1 alleles associated with promoter polymorphism. Immunogenetics 1997; 45:163-70.
22. Goldsmith ME, Madden MJ, Morrow CS, Cowan KH. A Y-box consensus sequence is required for basal expression of the human multidrug resistance (mdr1) gene. J Biol Chem 1993; 268:5856-60.
23. Lipson KE, Chen ST, Konieck J, Ku DH, Baserga R. S-phase-specific regulation by deletion mutants of the human thymidine kinase promoter. Proc Natl Acad Sci USA 1989; 86:6848-52.
24. Romero R, Lavine JE. Cytokine inhibition of the hepatitis B virus core promoter. Hepatol 1996; 23:17-23.
25. Davis GL, Hoofnagle JH, Waggoner JG. Acute type A hepatitis during chronic hepatitis B virus infection: association of depressed hepatitis B virus replication with appearance of endogenous alpha Interferon. J Med Virol 1984: 14:141-7.
26. Sheen IS, Liaw YF, Lin DY, Chu CM. Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study. J Infect Dis 1994; 170:1358-61.
27. Pastore G, Monno L, Santantonio T, Angarano G, Milella M, Gianelli A, Fiore JR. Hepatitis B virus clearance from serum and liver after acute hepatitis delta virus superinfection in chronic HBsAg carriers. J Med Virol 1990; 31:284-90.
28. González-Amaro R, García-Monzón C, García-Buey L et al. Induction of tumor necrosis factor α production by human hepatocytes in chronic viral hepatitis. J Exp Med 1994; 179:841-8.
29. Whitten TM, Quets AT, Schloemcr RH. Identification of the hepatitis B virus factor that inhibits expression of the beta Interferon gene. J Virol 1991; 65:4699-704.
30. Foster OR, Ackrill AM, Goldin RD, Kerr IM, Thomas HC, Stark GR. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double stranded RNA. Proc Natl Acad Sci USA 1991; 88:2888-92.
31. Hill AVS, Allsopp CEM, Kwiatkowski D et al. Common West African HLA antigens are associated with protection from severe malaria. Nature 1991; 352:595-600.